Essex Bio-technology Ltd ($1061) - buy or sell? Stock discussion, ideas, forum

Essex Bio-technology Ltd

Essex Bio-Technology Limited manufactures and sells biopharmaceutical products for the treatment and healing of surface wounds and organ wounds.

Industry: Biotechnology

Ticker	Exchange	ISIN	Name
$1061	HKEx Main Board	KYG312371035	Code: 1061

Recent news

TAI Ping Carpet International Ltd revenue jumped on 34.8% while EBITDA Margin decreased on 2.8 pp from 9.9% to 7.1%

Vision Fame International Holding Ltd revenue growth accelerated from 2.3% in FY2019 to 405% in FY2020

Kantone Holdings Ltd reports 13.0% EBITDA growth in 2020 and 0.61 pp EBITDA Margin growth from 5.7% to 6.3%

Heng Tai Consumables Group Ltd revenue dropped on 35.5% and EBITDA Margin dropped on 19.0 pp from -27.6% to -46.6%

Yat Sing Holdings Ltd revenue decreased on 8.4% and EBITDA Margin decreased on 2.2 pp from -1.7% to -3.9%

Art Textile Technology International Co Ltd Net Debt / EBITDA surged on 82.8x from 3.9x to 86.8x in 2020 while Revenue dropped on 24.7%

China Zenith Chemical Group Ltd revenue dropped on 39.8% while EBITDA Margin surged on 93.4 pp from -149% to -55.4%

Odella Leather Holdings Ltd revenue returned to growth in FY2020: increased 60.4% vs. 48.6% decline a year earliner

New World Development Co Ltd Net Income dropped on 85.3% and Revenue dropped on 23.1%

NWS Holdings Ltd reports 80.3% Net Income decline in 2020 and 3.4% Revenue decline

Twit about 1061 stock

Share your investment idea or question on Essex Bio-technology Ltd stock:

Latest twits on Essex Bio-technology Ltd (1061)

No twits yet. Be the first to post!

Have a question about 1061? Ask and other investors will be eager to help you.

Have an idea about 1061? Share it with other investors.

Essex Bio-technology Ltd news

28/03/2017 Looking for growth stocks? Pay attention to Essex Bio-technology Ltd

21/03/2017 Essex Bio-technology Ltd reports 29.9% Net Income growth in 2016 and 18.6% Revenue growth

25/03/2016 Essex Bio-technology Ltd demonstrates fast growth in fundamentals

18/03/2016 Essex Bio-technology Ltd Net Income surged on 39.4% in 2015 and EBITDA Margin increased slightly on 1.3 pp from 21.3% to 22.6%

25/03/2015 Essex Bio-technology Ltd demonstrated healthy growth in recent years

Essex Bio-technology Ltd stock price chart

Essex Bio-technology Ltd financials

mln. HKD	FY2010	FY2011	FY2012

Revenue	146.3	212.7	267.3
EBITDA	35.188	38.315	50.788
Net income	26.584	33.203	38.995
CAPEX	6.846	21.097	97.884
Debt	0.000	0.000	73.819
Cash	78.907	36.812	59.831

Essex Bio-technology Ltd news

About Essex Bio-technology Ltd

Essex Bio-Technology Limited manufactures and sells biopharmaceutical products for the treatment and healing of surface wounds and organ wounds.